Your browser doesn't support javascript.
loading
Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial.
Yamada, Shinichiro; Hashizume, Atsushi; Hijikata, Yasuhiro; Inagaki, Tomonori; Ito, Daisuke; Kishimoto, Yoshiyuki; Kinoshita, Fumie; Hirakawa, Akihiro; Shimizu, Shinobu; Nakamura, Tomohiko; Katsuno, Masahisa.
Affiliation
  • Yamada S; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Hashizume A; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Hijikata Y; Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Inagaki T; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ito D; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kishimoto Y; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kinoshita F; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Hirakawa A; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Shimizu S; Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Nakamura T; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Katsuno M; First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Ann Clin Transl Neurol ; 9(11): 1702-1714, 2022 11.
Article de En | MEDLINE | ID: mdl-36208052

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Amyotrophie bulbospinale liée à l'X / Méxilétine Type d'étude: Clinical_trials / Observational_studies Limites: Humans Langue: En Journal: Ann Clin Transl Neurol Année: 2022 Type de document: Article Pays d'affiliation: Japon Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Amyotrophie bulbospinale liée à l'X / Méxilétine Type d'étude: Clinical_trials / Observational_studies Limites: Humans Langue: En Journal: Ann Clin Transl Neurol Année: 2022 Type de document: Article Pays d'affiliation: Japon Pays de publication: États-Unis d'Amérique